APP and Alzheimer disease: Notably, a recent study showed that targeting the APP-Mint2 protein–protein interaction with a peptide-based inhibitor reduced amyloid β formation, which may present an alternative strategy in the pursuit of new therapeutic approaches in AD treatment39.